by assint
—
published
Feb 12, 2015
—
last modified
Apr 11, 2016 05:02 PM
—
filed under:
mergers,
report,
gsk,
novartis,
joint venture,
cease and desist agreement,
agreement
CADE recommended to the Tribunal the approval of a joint venture conditioned to the signature of a Merger Control Agreement
Located in
Press Releases
